CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit ...

Detailed price information for Broadridge Financial Solutions Llc (BR-N) from The Globe and Mail including charting and trades.

Presenting INTASYL siRNA Drug Technology King of Prussia, Pennsylvania–(Newsfile Corp. – November 17, 2025) – Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA ...

Record-setting quarter, one more example of our strong growth and continued diversification.TPV at record high of US$10.4 billion, growing nearly ...

Clinical Trial has Advanced to Fifth and Final Cohort at Maximum Dose of INSTASYL PH-762 in Skin Cancer Trial Positive Pathology Results at Maximum Dose: 100% Tumor Clearance (Complete Response) ...

Empery Digital Inc. (NASDAQ: EMPD) ("Empery Digital", the "Company" or "we"), an E-bike and Bitcoin Treasury company, today ...

Record Q3 revenue of $123.3 million, up 21.6% year over yearGross margin increased from 33.2% to 37.6%, a 4.4 percentage point improvement year ...

Phase 3 accelerated approval trial of IFx-2.0 as adjunctive therapy with Keytruda® (pembrolizumab) as a first-line therapy for advanced and metastatic Merkel cell ...

Banzai believes its non-GAAP financial measure ARR is more meaningful in evaluating its performance. The Company’s management team evaluates its financial and operating results utilizing this non-GAAP ...

DarioHealth Corp. (NASDAQ: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, today announced financial results for the third quarter ended September 30, 2025, along with ...

Third Quarter Revenues Increased to $0.8 Million Due to Higher Service Revenues and Expects 2025 Full Year Revenues of Approximately $4 MillionFortified Balance Sheet Including $7.0 Million ATM Facili ...

Generated $131 million from the successful business combination with GSR III Acquisition Corp. and related equity financing ...